Mifepristone is back at the Supreme Court in case over mailing the medication abortion drug

After a Fifth Circuit ruling Friday that would end mailing of the mifepristone, drugmakers asked the justices to act immediately to keep the FDA policy allowing mailing in place.
READ THE LATEST
Law Dork
Law Dork
The Supreme Court, law, politics, and more.
Recommendations
View all 22
ET Write Home
Emily Tamkin
The Present Age
Parker Molloy
User's avatar
Heather Cox Richardson